[Congressional Record Volume 155, Number 118 (Friday, July 31, 2009)]
[Extensions of Remarks]
[Pages E2140-E2141]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                          EARMARK DECLARATION

                                 ______
                                 

                          HON. GARY G. MILLER

                             of california

                    in the house of representatives

                         Friday, July 31, 2009

  Mr. GARY G. MILLER of California. Madam Speaker, pursuant to the 
Republican Leadership standards on earmarks, I am submitting the 
following information regarding earmarks I received as part of the FY 
2010 Defense Appropriations Bill.
  Requesting Member: Congressman Gary G. Miller
  Bill Number: H.R. 3326
  Account: Navy--Research, Development, Test, and Evaluation
  Legal Name of Requesting Entity: L-3 Power Paragon
  Address of Requesting Entity: 901 E. Ball Road, Anaheim, California 
92805
  Funding Secured: $2,000,000
  Description of Request: This project is a design build prototype for 
a hybrid electric drive (HED) for the CG 47 Class Cruisers for the U.S. 
Navy. This project contributes to the future of environmentally sound, 
fuel-efficient propulsion. The Navy believes that this improvement 
would realize a significant savings per year per ship. This HED for 
surface combatants such as the CG 47 would significantly reduce fuel 
costs, increase ship endurance and range, produce less environmental 
emissions, increase ship survivability through reduce signatures, and 
provide increased overall ship electric power generation capacity. This 
installation would leverage advances in lighter weight and more 
efficient electric propulsion technologies that have resulted from the 
Office of Naval Research investments over the last several years.
  Requesting Member: Congressman Gary G. Miller
  Bill Number: H.R. 3326
  Account: Army--Research, Development, Test, and Evaluation
  Legal Name of Requesting Entity: Athena GTX
  Address of Requesting Entity: 10291 Trademark Street, Rancho 
Cucamonga, CA 91730
  Funding Secured: $3,000,000
  Description of Request: This project will complete the development of 
a Wireless Medical Monitor (WiMed) allowing a combat medic to monitor 
vital signs and triage wounded soldiers in real time. Current medical 
triage monitors and vital signs data tracking tools are complex, heavy, 
and have bulky connections. They are also large, costly, and difficult 
to use. Using proven technology, the WiMed provides increased 
capability at a much lower cost. By streamlining casualty care and 
providing patient trend data, life saving decisions lead to earlier 
interventions and improved outcomes. Prototypes have demonstrated 
WiMed's ability to improve critical care by linking all patient care 
within the same wireless systems and platforms already in service. Once 
placed on a patient at the point of wounding, WiMed stays with that 
patient throughout triage and care. WiMed works with standard blood 
pressure cuffs or a simple highly mobile forehead stick-on sensor and 
integrates many inputs, including: pulse oximetry, blood pressure, 
temperature, skin humidity, and electrocardiogram. The patient's state 
is broadcast via Wi-Fi technology to any number of users with linked 
platforms anywhere in the world at any time and they can receive vital 
signs information on any number of casualties that have the WiMed 
monitoring equipment placed on them. Continued funding for this project 
will greatly improve combat casualty care outcomes.
  Requesting Member: Congressman Gary G. Miller
  Bill Number: H.R. 3326
  Account: Navy--Research, Development, Test, and Evaluation
  Legal Name of Requesting Entity: Sabtech
  Address of Requesting Entity: 17320 Dahlgren Road, Dahlgren, Virginia 
22448
  Secondary Address: 23231 La Palma Avenue, Yorba Linda, California 
92887
  Funding Secured: $5,000,000
  Description of Request: The United States Navy's Aegis ship 
modernization plan includes modernization of the ships' basic hull, 
mechanical, and electrical equipment, and modernization of their combat 
systems. In both areas, the Navy plans to install new systems or 
components that are more capable than the ones they are to replace. 
Some of the planned changes are intended to permit naval ships to be 
operated with a smaller crew, thereby reducing their annual operation 
and support costs. Planned changes to the ships' combat systems are 
intended to, among other things, begin shifting their Aegis computers 
and software to a more open architecture meaning, in general terms, an 
arrangement that uses non-proprietary computers and software. The Navy 
believes that moving to an Aegis open architecture will permit the 
Aegis system to be updated over the remainder of the ships' lives more 
easily and less expensively, using contributions from a variety of 
firms. This funding will be used to conduct a demonstration to remove 
existing Legacy NTDS computer interfaces found in Baseline 7, Cruiser 
Modernization, and Aegis Modernization. This request was also submitted 
to the House Armed Services Committee in order to secure authorization 
statutes in the Fiscal Year 2010 Defense Authorization Act.
  Requesting Member: Congressman Gary G. Miller
  Bill Number: H.R. 3326
  Account: Navy--Research, Development, Test, and Evaluation
  Legal Name of Requesting Entity: Naval Health Research Center
  Address of Requesting Entity: 140 Sylvester Road, San Diego, 
California 92106
  Funding Secured: $3,000,000
  Description of Request: In the United States, prostate cancer is the 
most common cancer in men, with an incidence rate of 16 percent of the 
general population. The primary treatment of prostate cancer usually 
includes radical prostatectomy surgery, which provides a good 
management of the local tumor in most of the patients. Unfortunately, 
in 15 to 40 percent of patients, recurrent prostate cancer is possible 
within five years of surgery. Though recurrent prostate cancer 
following failure of local control is not curable, patients with 
recurrent cancer are perfect candidates for immunotherapy, a new 
approach that is still under clinical investigation for oncology 
applications. The U.S. Navy, through its Naval Health Research Center 
in San Diego, California, is in a unique position to advance 
immunotherapeutic approaches for prostate cancer that have so far shown 
efficacy in animal models. With Fiscal Year 2009 funding, the U.S. Navy 
Cancer Vaccine Program implemented a Phase 1A/1B clinical trial of its 
developed vaccine for prostate cancer patients at the Veterans Medical 
Center. Forty-eight U.S. military veterans who have received previous 
treatment (surgery, radiation or radioactive seed implants) and now 
have a rising PSA participated in the study. With proof of minimal 
toxicity of the PSA vaccine in the Phase 1A clinical trial, a second 
clinical trial of patients with rising PSAs and nonpalpable biopsy 
confirmed prostate cancer would be initiated with Fiscal Year 2010 
funding. This program will have direct benefits for the health care 
options

[[Page E2141]]

of our nation's active Armed Forces, retired veterans, and the general 
American population.

                          ____________________